Moreover, NMI cases appear milder and frequently consist of TSC patients whose pathogenic variant presents somatic mosaicism or lies in regulatory segments of either TSC1 or TSC2 genes [13]. This evidence concerns the gene TSC2 and tuberous sclerosis.